Focus Feature: KPSC teams with Moderna, Pfizer-BioNTech to assess real-world effectiveness of COVID-19 vaccines
Researchers from Kaiser Permanente Southern California are collaborating with Moderna and Pfizer-BioNTech, the makers of the 2 first authorized COVID-19 vaccines, to study their vaccines’ effectiveness in real-world settings in preventing the disease and reducing its severity.
R&E News and Features
Pneumonia vaccine may affect course of COVID-19
New research showed that older adults who received the pneumonia vaccine PCV13 were diagnosed with COVID-19 less often, and when they were, had less severe outcomes.
Residents lead advances in understanding of “broken heart” syndrome
Research led by internal medicine residents at the Kaiser Permanente Los Angeles Medical Center has surfaced new insights into Takotsubo syndrome, a condition that closely resembles a heart attack. Most importantly, the findings link beta-blocker treatment with improved clinical outcomes.
Diabetic eye damage reflects future cardiovascular risks
New research shows that greater severity of diabetic retinopathy is strongly associated with a higher risk of heart attacks, strokes, congestive heart failure, and death from any cause.
New CIRT research projects aim to improve care
The Care Improvement Research Team has awarded funds for 7 new research projects led by Southern California Permanente Medical Group scientists and physician researchers on COVID-19 and other health topics to help improve the care physicians provide for their patients.
In the News
Severe Obesity Raises Risk of COVID-19 Hospitalization and Death, Study Finds
The New York TimesMarch 8, 2021
Five questions...
for Dr. Shireen Fatemi
Dr. Shireen Fatemi, an endocrinologist at the Kaiser Permanente Panorama City Medical Center, was recently named the 2020 Southern California Permanente Medical Group Physician Researcher of the Year! Read more about her research and her hobbies in this Q&A.